7138046214

7138046214

Vision Optique

Ocular Clinical Trials

Book Appointment

Welcome to Our Clinical Research Center

Welcome to the Ocular Aesthetics research center at Vision Optique, operated under Ocular Clinical Trials. We are proud to lead the way in ocular clinical research and are committed to helping advance the future of eye care.

Since 2020, we’ve conducted 15 pre-clinical, Phase III, and Phase IV clinical trials, and we continue to actively enroll participants in new studies. Our research focuses on key areas including dry eye and ocular surface disease management, Demodex blepharitis, ocular rosacea, myopia management, astigmatism and presbyopia contact lenses, specialty contact lenses, ophthalmic glasses, presbyopia treatment solutions, refractive surgery co-management, diagnostic tools, and Smart Eyewear technologies.

Explore our current studies, meet the knowledgeable team behind our research, and find out how you can be part of the future of eye care.

Meet the Team

+

Dr. Bridgitte Shen Lee

Principal Investigator

+

Dr. Bradley S. Owens

Sub-Investigator

+

Dr. Noelle Abraham

Sub-Investigator

+

Fatima Alshamsi

Clinical Research Coordinator

Dr. Vanesa Flores

Sub-Investigator

Jasmine

Clinical Research Coordinator

Research Focus

Contact Lens Studies

We participate in clinical trials to help develop next-generation contact lenses and solutions. Studies may include:

  • Testing new lens materials for better oxygen permeability, improved wearer comfort, and vision
  • Evaluating lenses for dry eye, astigmatism, presbyopia, and myopia control or management
  • Studying the effects of lens care systems  on contact lens and eye health
  • Developing contact lenses with built-in drug delivery systems

Ophthalmic Pharmaceutical Research

Our research team is actively partnering with leading eye care companies in the scientific study and development of drugs and therapies specifically designed to diagnose, treat, or prevent diseases and conditions of the eye. Our research efforts include:

  • Discovery and development of new pharmaceutical agents or compounds targeting ocular tissues
  • Formulation of pharmaceutical drugs suitable for ocular delivery (e.g., eye drops, ointments, nasal spray)
  • Evaluation of the efficacy and safety of ocular drugs and medical devices through FDA-approved clinical trials

Myopia Management or Myopia Control Studies

Our clinical research team has been involved in innovative studies to manage and reduce the progression of myopia (nearsightedness), particularly in children and adolescents. The main purpose of myopia management is to slow the progression and reduce the risk of developing more severe myopia. High myopia increases the risk for sight-threatening eye diseases later in life. While myopia cannot be reversed, managing its progression can lead to milder prescriptions in adulthood and a lesser risk of conditions like retinal detachment, cataracts, glaucoma, and myopic maculopathy.

Current treatment options include: specialty eyeglasses, daytime soft contact lenses, nighttime Ortho-k lenses, and low-dose atropine eye drops at bedtime.

Diagnostic AI Technology and Equipment 

Our research team is advancing the use of AI-powered diagnostic systems and next-generation imaging technologies to support early detection, accurate diagnosis, and ongoing monitoring of ocular diseases. We look forward to collaborating with leading eye care companies to develop new technology and equipment in eye care.

Participating in an ocular clinical study can offer valuable benefits:

  • Participants may receive new therapies before they become available, potentially benefiting from innovations not yet on the market.
  • Clinical trials are closely monitored by medical professionals, often offering more frequent check-ups and detailed assessments than standard care.
  • Your involvement helps advance scientific understanding and improve treatment options for eye diseases, potentially benefiting others with similar conditions.
  • Some studies focus on diseases with limited treatment options, offering new hope for people who haven’t responded well to standard therapies.
  • Participants are compensated for their time and effort. In many cases, all trial-related treatments, medications, and assessments are provided at no cost.

Currently Enrolling

Ocular Rosacea Study

Ocular rosacea leads to redness, inflammation, and sensitivity. It may or may not be associated with facial rosacea. Triggers can include:

  • Demodex mites
  • Blocked meibomian glands
  • Environmental and lifestyle factors

We are currently enrolling participants for an ocular rosacea clinical study. If you experience these triggers, we invite you to connect with our team for a screening.

To express interest in either study, please email us at: [email protected]

How to Participate

Contact Fatima Alshamsi, our clinical research coordinator:

She’ll walk you through the screening process, answer your questions, and help determine if you’re eligible to enroll in our upcoming studies.

Our Services

Where to Find Us

Directions

We are conveniently located at 2900 Weslayan Street, near the corner of Weslayan and West Alabama (across from Davanti Restaurant and APTEEK Pharmacy). We are on the first floor of a tall black building.

Parking spaces have been reserved for our patients at the front of the building. Additional parking is also available in the adjacent parking garage.

Our Address

2900 Weslayan Street, Suite 100
Houston, TX 77027

Contact Information

Phone: 713-838-2020
[email protected]

Hours of Operation

Monday
Closed
Tuesday
8:30 AM5:30 PM
Wednesday
8:30 AM5:30 PM
Thursday
8:30 AM5:30 PM
Friday
8:30 AM4:30 PM
Saturday
8:00 AM2:00 PM
Sunday
Closed
instagram facebook facebook2 pinterest twitter google-plus google linkedin2 yelp youtube phone location calendar share2 link star-full star-half star star-half chevron-right chevron-left chevron-down chevron-up envelope fax